3
Braz Dent Sci 2023 Oct/Dec; 26 (4):/
Marques SS et al.
Unlocking the secrets of saliva: the promising potential of salivary biomarkers for evaluating crack use
Marques SS et al.
Unlocking the secrets of saliva: the promising potential of
salivary biomarkers for evaluating crack use
GRZ: Substantial contributions to the conception,
drafting of the article, translation and final
approval of the version to be published. FS:
Critical review, final approval of the version
to be published. HSM: Critical review, final
approval of the version to be published. JDA:
Conception of the letter, revising it critically for
important intelectual content and nal approval
of the version to be published. MRA: Substantial
contributions to the letter, revising it critically for
important intelectual content and nal approval
of the version to be published.
Conict of Interest
No conicts of interest declared concerning
the publication of this article.
Funding
The authors disclosed receipt nancial support
from São Paulo Research Foundation (FAPESP)
for the research and authorship through grants
#2020/10362-0 (Almeida JD), #2021/14395-3
(Oliveira TMC) and grant #2021/06500-1
(Zucco GR), and National Council for Scientic
and Technological Development (CNPq, grants
numbers 406761/2022-1,311933/2021-1).
Regulatory Statement
None.
REFERENCES
1. Butler AJ, Rehm J, Fischer B. Health outcomes associated with
crack-cocaine use: systematic review and meta-analyses. Drug
Alcohol Depend. 2017;180:401-16. http://dx.doi.org/10.1016/j.
drugalcdep.2017.08.036. PMid:28982092.
2. Ribeiro M, Perrenoud LO, Duailibi S, Duailibi LB, Madruga C,
Marques ACPR, et al. The Brazilian drug policy situation: the
public health approach based on research undertaken in a
developing country. Public Health Rev. 2013;35(2):7. http://
dx.doi.org/10.1007/BF03391706.
3. Ribeiro M, Duailibi S, Frajzinger R, Alonso AL, Marchetti L,
Williams AV,etal. The Brazilian ‘Cracolândia’ open drug scene
and the challenge of implementing a comprehensive and
effective drug policy. Addiction. 2016;111(4):571-3. http://dx.doi.
org/10.1111/add.13151. PMid:26497639.
4. Abdalla RR, Madruga CS, Ribeiro M, Pinsky I, Caetano R,
Laranjeira R. Prevalence of cocaine use in Brazil: data from
the II Brazilian national alcohol and drugs survey (BNADS).
Addict Behav. 2014;39(1):297-301. http://dx.doi.org/10.1016/j.
addbeh.2013.10.019. PMid:24455783.
5. Antoniazzi RP, Zanatta FB, Ardenghi TM, Feldens CA. The use of
crack and other illicit drugs impacts oral health-related quality
of life in Brazilians. Oral Dis. 2018;24(3):482-8. http://dx.doi.
org/10.1111/odi.12786. PMid:28949432.
6. Brand HS, Gonggrijp S, Blanksma CJ. Cocaine and oral health.
Br Dent J. 2008;204(7):365-9. http://dx.doi.org/10.1038/
sj.bdj.2008.244. PMid:18408681.
7. Riva R, Rotemberg E, Sanguinetti M,etal. Drug dependence,
bruxism and temporomandibular disorders comparative
analysis of two populations: nationwide sample and portal
amarillo’s population in treatment for problematic drug use.
Odontoestomatologia [Internet]. 2014 [cited 2023 may 18];
16(24):26-33. Available from: http://www.scielo.edu.uy/pdf/
ode/v16n24/en_v16n24a05.pdf
8. Teoh L, Moses G. Drug-induced bruxism. Aust Prescr. 2019
Aug;42(4):121. https://.
9. Nassar P, Ouanounou A. Cocaine and methamphetamine:
pharmacology and dental implications. Can J Dent Hyg.
2020;54(2):75-82. PMid:33240367.
10. Cury PR, Oliveira MGA, Andrade KM, de Freitas MDS, dos Santos
JN. Dental health status in crack/cocaine-addicted men: a cross-
sectional study. Environ Sci Pollut Res Int. 2017;24(8):7585-90.
http://dx.doi.org/10.1007/s11356-017-8404-z. PMid:28120223.
11. Antoniazzi RP, Palmeira RV, Schöffer C, Santos BZ, Zanatta FB,
Feldens CA. Use of crack cocaine increases tooth loss. Am J
Dent. 2021;34(6):317. PMid:35051319.
12. Antoniazzi RP, Zanatta FB, Rösing CK, Feldens CA. Association
among periodontitis and the use of crack cocaine and other
illicit drugs. J Periodontol. 2016;87(12):1396-405. http://dx.doi.
org/10.1902/jop.2016.150732. PMid:27389964.
13. Sordi MB, Massochin RC, Camargo AR, Lemos T, Munhoz EA.
Oral health assessment for users of marijuana and cocaine/
crack substances. Braz Oral Res. 2017;31:e102. http://dx.doi.
org/10.1590/1807-3107bor-2017.vol31.0102. PMid:29267663.
14. Souza SJR, Santos AC, Albini MB,etal. Oral health impact profile
and associated variables in southern Brazilian drug users. Iran J
Public Health. 2018;47(10):1466. PMid:30524976.
15. Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Rehman R, Ur Rehman
I. Advances of proteomic sciences in dentistry. Int J Mol Sci.
2016;17(5):728. http://dx.doi.org/10.3390/ijms17050728.
PMid:27187379.
16. Pedersen AML, Sørensen CE, Proctor GB, Carpenter GH,
Ekström J. Salivary secretion in health and disease. J Oral
Rehabil. 2018;45(9):730-46. http://dx.doi.org/10.1111/joor.12664.
PMid:29878444.
17. Chaiben CL, Batista TBD, Penteado CAS, Barbosa MCM, Ventura
TMO, Dionizio A, et al. Salivary proteome analysis of crack
cocaine dependents. Arch Oral Biol. 2021;121:104952. http://
dx.doi.org/10.1016/j.archoralbio.2020.104952. PMid:33186792.
18. Chaiben CL, Macedo NF, Batista TBD, Penteado CAS, Ventura
TMO, Dionizio A, et al. Salivary protein candidates for
biomarkers of oral disorders in people with a crack cocaine use
disorder. J Appl Oral Sci. 2023;31:e20220480. http://dx.doi.
org/10.1590/1678-7757-2022-0480. PMid:37194792.
19. Drummer OH. Introduction and review of collection techniques
and applications of drug testing of oral fluid. Ther Drug Monit.
2008;30(2):203-6. PMid:18367981.
20. Pil K, Verstraete A. Current developments in drug testing in
oral fluid. Ther Drug Monit. 2008;30(2):196-202. http://dx.doi.
org/10.1097/FTD.0b013e318167d563. PMid:18367980.
21. Kuwayama K, Miyaguchi H, Yamamuro T, Tsujikawa K, Kanamori
T, Iwata YT, et al. Effectiveness of saliva and fingerprints as
alternative specimens to urine and blood in forensic drug testing.
Drug Test Anal. 2016;8(7):644-51. http://dx.doi.org/10.1002/
dta.1831. PMid:26074137.